Case Report: Cytokeratin-positive interstitial reticulum cell tumor with HLA loss of heterozygosity - Top-Institutions - MDSpire

Case Report: Cytokeratin-positive interstitial reticulum cell tumor with HLA loss of heterozygosity

  • By

  • Wen Liu

  • Yan Zhang

  • Yuqing Wei

  • Yinan Hu

  • Xinmiao Zhang

  • Jingli Xue

  • Peifeng Li

  • June 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Immunogenomics

  • #3

    University Medical Center Hamburg-Eppendorf
    University Medical Center Hamburg-Eppendorf

    Hamburg, Germany

    Key Differentiators

    • Oncology
    • Pathology

  • #4

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Oncology
    • Pathology

  • #5

    Zhujiang Hospital of Southern Medical University
    Zhujiang Hospital of Southern Medical University

    Guangzhou, China

    Key Differentiators

    • Oncology
    • Surgical Oncology

Original Source(s)

Case Report: Cytokeratin-positive interstitial reticulum cell tumor with HLA loss of heterozygosity

  • by Wen Liu, Yan Zhang, Yuqing Wei, Yinan Hu, Xinmiao Zhang, Jingli Xue, Peifeng Li

  • June 2, 2026

Related Content

Target receptor expression dictates the selective intra-tumoral targeting of CD8+ T cells by eciskafusp alfa in matched PBMCs and TILs from CPI-naïve patients

Case Report: Intramedullary solitary fibrous tumor at the C7-T1 level diagnosed by STAT6 and treated with maximal safe resection

Total ureteral replacement with a small intestinal graft as a reconstructive stage of combined treatment for recurrent colorectal cancer: case report